306 related articles for article (PubMed ID: 28733870)
1. Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.
Marinoff AE; Ma C; Guo D; Snuderl M; Wright KD; Manley PE; Al-Sayegh H; Sinai CE; Ullrich NJ; Marcus K; Haas-Kogan D; Goumnerova L; London WB; Kieran MW; Chi SN; Fangusaro J; Bandopadhayay P
J Neurooncol; 2017 Oct; 135(1):201-211. PubMed ID: 28733870
[TBL] [Abstract][Full Text] [Related]
2. Childhood intracranial ependymoma: twenty-year experience from a single institution.
Shu HK; Sall WF; Maity A; Tochner ZA; Janss AJ; Belasco JB; Rorke-Adams LB; Phillips PC; Sutton LN; Fisher MJ
Cancer; 2007 Jul; 110(2):432-41. PubMed ID: 17559078
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
Lin Y; Jea A; Melkonian SC; Lam S
J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after first relapse of childhood intracranial ependymoma.
Tsai JW; Manoharan N; Alexandrescu S; Zimmerman MA; Scully J; Chordas C; Clymer J; Wright KD; Filbin M; Ullrich NJ; Marcus KJ; Haas-Kogan D; Chi SN; Bandopadhayay P; Yeo KK
Pediatr Blood Cancer; 2021 Aug; 68(8):e28930. PubMed ID: 33565268
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and treatment options for paediatric ependymomas.
Vaidya K; Smee R; Williams JR
J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
[TBL] [Abstract][Full Text] [Related]
7. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
[TBL] [Abstract][Full Text] [Related]
8. Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location.
Lopez-Rivera V; Dono A; Abdelkhaleq R; Sheth SA; Chen PR; Chandra A; Ballester LY; Esquenazi Y
Clin Neurol Neurosurg; 2020 Dec; 199():106282. PubMed ID: 33045626
[TBL] [Abstract][Full Text] [Related]
9. A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors.
Horn B; Heideman R; Geyer R; Pollack I; Packer R; Goldwein J; Tomita T; Schomberg P; Ater J; Luchtman-Jones L; Rivlin K; Lamborn K; Prados M; Bollen A; Berger M; Dahl G; McNeil E; Patterson K; Shaw D; Kubalik M; Russo C
J Pediatr Hematol Oncol; 1999; 21(3):203-11. PubMed ID: 10363853
[TBL] [Abstract][Full Text] [Related]
10. Patterns of relapse for children with localized intracranial ependymoma.
De B; Khakoo Y; Souweidane MM; Dunkel IJ; Patel SH; Gilheeney SW; De Braganca KC; Karajannis MA; Wolden SL
J Neurooncol; 2018 Jun; 138(2):435-445. PubMed ID: 29511977
[TBL] [Abstract][Full Text] [Related]
11. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors.
Zacharoulis S; Ji L; Pollack IF; Duffner P; Geyer R; Grill J; Schild S; Jaing TH; Massimino M; Finlay J; Sposto R
Pediatr Blood Cancer; 2008 Feb; 50(2):231-5. PubMed ID: 17610266
[TBL] [Abstract][Full Text] [Related]
12. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.
Perilongo G; Massimino M; Sotti G; Belfontali T; Masiero L; Rigobello L; Garrè L; Carli M; Lombardi F; Solero C; Sainati L; Canale V; del Prever AB; Giangaspero F; Andreussi L; Mazza C; Madon E
Med Pediatr Oncol; 1997 Aug; 29(2):79-85. PubMed ID: 9180907
[TBL] [Abstract][Full Text] [Related]
13. Personalizing age-specific survival prediction and risk stratification in intracranial grade II/III ependymoma.
Deng X; Zhang X; Yang L; Lu X; Fang J; Yu L; Li D; Sheng H; Yin B; Zhang N; Lin J
Cancer Med; 2020 Jan; 9(2):615-625. PubMed ID: 31793749
[TBL] [Abstract][Full Text] [Related]
14. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
[TBL] [Abstract][Full Text] [Related]
15. Timing of adjuvant radiotherapy and treatment outcome in childhood ependymoma.
Liu AP; Shing MM; Yuen HL; Li CH; Ling SC; Luk CW; Ha SY; Li CK; Kwong DL; Chan GC
Pediatr Blood Cancer; 2014 Apr; 61(4):606-11. PubMed ID: 24167035
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome in patients harboring intracranial ependymoma.
Kawabata Y; Takahashi JA; Arakawa Y; Hashimoto N
J Neurosurg; 2005 Jul; 103(1):31-7. PubMed ID: 16121970
[TBL] [Abstract][Full Text] [Related]
17. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.
Tarapore PE; Modera P; Naujokas A; Oh MC; Amin B; Tihan T; Parsa AT; Ames CP; Chou D; Mummaneni PV; Weinstein PR
Neurosurgery; 2013 Aug; 73(2):247-55; discussion 255. PubMed ID: 23670032
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of outcome in intramedullary ependymoma and astrocytoma.
Hamilton KR; Lee SS; Urquhart JC; Jonker BP
J Clin Neurosci; 2019 May; 63():168-175. PubMed ID: 30833131
[TBL] [Abstract][Full Text] [Related]
19. Population based analysis ependymoma patients in Alberta from 1975 to 2007.
Roldán Urgoiti GB; Singh AD; Tsang RY; Nordal RA; Lim G; Chan JA; Starreveld YP; de Robles PA; Biagioni BJ; Hamilton MG; Easaw JC
Can J Neurol Sci; 2014 Nov; 41(6):742-7. PubMed ID: 25382385
[TBL] [Abstract][Full Text] [Related]
20. Impact of radiation therapy and extent of resection for ependymoma in young children: A population-based study.
Snider CA; Yang K; Mack SC; Suh JH; Chao ST; Merchant TE; Murphy ES
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
